Disclosures: Ryo Sasaki: Nothing to Disclose, Tsuyoshi Ishikawa: Nothing to Disclose, Taro Takami: Nothing to Disclose 523 METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IS ASSOCIATED WITH LIVER FIBROSIS IN HEPATITIS C Wesal Elgretli 1 Mohamed Shengir 1 Solomon Sasson 2 Ramanakumar Agnihotram V 3 Luz Esther Ramos Ballesteros 4 Marc Deschenes 5 Philip Wong 5 Tianyan Chen 5 Nadine Kronfli 6 Alexa Keeshan 7 Saniya Tandon 8 Curtis Cooper 8 Giada Sebastiani 9 , 1 Division of Experimental Medicine, McGill University, Montreal, Canada, 2 Department of Medicine, University of British Columbia, Vancouver, Canada, 3 Research Institute, McGill University Health Center, Montreal, Canada, 4 Chronic Viral Illness Services, McGill University Health Center, Montreal, Canada, 5 Department of Medicine, McGill University Health Centre, Montreal, Canada, 6 Chronic Viral Illness Service, McGill University Health Centre, Montreal, Canada, 7 Division of Infectious Diseases, Ottawa Hospital Research Institute, Ottawa, Canada, 8 Division of Infectious Diseases, Hospital Research Institute, Ottawa, Canada, 9 Chronic Viral Illness Service

Twins studies can be used to separate genetics from environmental factors, providing clues to the genetic component of allergic diseases
Clin Exp Dermatol (2012) 37(1):624
In a multicentre, examiner-blind, clinical and neurophysiological study lasting 4 months, 120 hands from 82 patients with mild-to-moderate carpal tunnel syndrome were examined at baseline and 10, 60, and 120 days after treatment with 500 mg of acetyl-l-carnitine twice daily for 10 days intramuscularly followed by oral administration at 500 mg twice daily for 4 months
The amount absorbed buccally versus the amount swallowed and subjected to the impaired GI pathway has not been quantified in published research